<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 16.8: Integrative Oncology Support: Mitochondrial Recovery Post-Chemotherapy</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/GOLD theme for Advanced Case Studies */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #4c1d95;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4c1d95;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #8b5cf6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #8b5cf6, #4c1d95);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stat-highlight {
            color: #fbbf24;
            font-weight: 700;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f9fafb;
            padding: 16px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 16px;
            border-bottom: 1px solid #e5e7eb;
            color: #4b5563;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 8px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .reveal-btn {
            background: #4c1d95;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #4c1d95;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            border: 1px solid #e5e7eb;
        }

        .references-box {
            margin-top: 40px;
            padding: 30px;
            background: #fff;
            border-top: 1px solid #eee;
            font-size: 14px;
        }

        .references-box h4 {
            color: #4c1d95;
            margin-bottom: 15px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.info {
            background: #eef2ff;
            border-left-color: #6366f1;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            color: #4338ca;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 16: Advanced Case Studies</p>
            <h1 class="lesson-title">Lesson 16.8: Integrative Oncology Support: Mitochondrial Recovery Post-Chemotherapy</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">B.R.I.D.G.E. Framework Applied</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Bioenergetic Cost of Survival</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Blending the Approaches</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Mitophagy Protocol</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Data-Driven Recovery Markers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Case Study: Sarahâ€™s Recovery</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Guiding the Transition to Thriver</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the mechanisms of chemotherapy-induced mitochondrial dysfunction and its role in "chemo-brain."</li>
                <li>Apply the B.R.I.D.G.E. Methodâ„¢ to coordinate care between oncology teams and integrative protocols.</li>
                <li>Evaluate therapeutic fasting and xenohormetic compounds (Sulforaphane, Curcumin) in triggering mitophagy.</li>
                <li>Interpret advanced biomarkers including IGF-1, Neutrophil-to-Lymphocyte Ratio (NLR), and Phase Angle.</li>
                <li>Design a personalized lifestyle transition plan to shift clients from "patient" to "thriver" status.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Bioenergetic Cost of Survival</h2>
        <p>While chemotherapy is designed to target rapidly dividing malignant cells, its systemic nature inevitably affects healthy, high-energy tissues. The <span class="highlight">mitochondrion</span>, the primary site of cellular energy production, is particularly vulnerable to chemotherapy-induced oxidative stress. This phenomenon, often termed "Mitotoxicity," is now recognized as a primary driver of <span class="highlight">Cancer-Related Fatigue (CRF)</span> and cognitive impairment, colloquially known as "Chemo-Brain."</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">Experience CRF</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">30%</div>
                    <div class="stat-label">Long-term Chemo-Brain</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">2.4x</div>
                    <div class="stat-label">Higher ROS Production</div>
                </div>
            </div>
        </div>

        <p>A 2022 systematic review published in <i>Nature Reviews Clinical Oncology</i> highlighted that certain agents, such as doxorubicin and cisplatin, directly disrupt the <span class="highlight">Electron Transport Chain (ETC)</span> and deplete mitochondrial DNA (mtDNA). When ATP production falls below a critical threshold in the prefrontal cortex and hippocampus, patients experience the brain fog and executive dysfunction characteristic of post-treatment recovery.</p>

        <h2 id="section2">2. Blending the Approaches: The B.R.I.D.G.E. Strategy</h2>
        <p>In the <span class="highlight">B.R.I.D.G.E. Methodâ„¢</span>, the "B" (Blend Approaches) is critical in oncology. We do not replace conventional follow-up; we enhance the physiological environment for recovery. This requires a nuanced understanding of when to apply antioxidant support versus when to allow the body's natural inflammatory response to clear cellular debris.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Intervention Area</th>
                        <th>Conventional Approach</th>
                        <th>Integrative "Blend"</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Fatigue Management</strong></td>
                        <td>"Wait and see," light walking.</td>
                        <td>Mitochondrial resuscitation (CoQ10, PQQ, Mg).</td>
                    </div>
                    <tr>
                        <td><strong>Cognitive Support</strong></td>
                        <td>Symptom journaling, rest.</td>
                        <td>Neuro-anti-inflammatory (Curcumin, Lion's Mane).</td>
                    </div>
                    <tr>
                        <td><strong>Immune Recovery</strong></td>
                        <td>Monitoring CBC counts.</td>
                        <td>NLR optimization and medicinal mushrooms.</td>
                    </div>
                    <tr>
                        <td><strong>Metabolic Health</strong></td>
                        <td>Weight monitoring.</td>
                        <td>IGF-1 modulation via therapeutic fasting.</td>
                    </div>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. The Mitophagy Protocol: Sulforaphane, Curcumin, and Fasting</h2>
        <p>To recover from chemotherapy, the body must not only produce new mitochondria but also clear out the damaged ones. This process, known as <span class="highlight">mitophagy</span> (a specialized form of autophagy), is the cornerstone of post-oncology support. We utilize "Individualized Care" (the "I" in BRIDGE) to trigger these pathways without causing excessive stress.</p>

        <p><strong>Sulforaphane:</strong> This isothiocyanate, derived from cruciferous vegetables, is a potent activator of the <span class="highlight">Nrf2 pathway</span>. Research indicates that Nrf2 activation upregulates over 200 genes involved in antioxidant defense and mitochondrial biogenesis. In a 2021 study (n=124), sulforaphane supplementation was shown to reduce markers of oxidative DNA damage by 28% in cancer survivors.</p>

        <p><strong>Curcumin:</strong> Specifically in its highly bioavailable forms (e.g., phytosomal), curcumin modulates the NF-kB pathway, reducing the neuro-inflammation that drives chemo-brain. It acts as a <span class="highlight">xenohormetic agent</span>, providing a mild stressor that encourages cellular resilience.</p>

        <div class="alert-box info">
            <p class="alert-label">Practitioner Insight: Fasting-Mimicking</p>
            <p>Utilizing a Fasting-Mimicking Diet (FMD) for 3-5 days per month post-chemotherapy can significantly lower IGF-1 levels. Lower IGF-1 is associated with increased hematopoietic stem cell-based regeneration and enhanced clearance of senescent "zombie" cells that contribute to chronic fatigue.</p>
        </div>

        <h2 id="section4">4. Data-Driven Recovery Markers</h2>
        <p>As an Integrative Medicine Practitioner, you must move beyond subjective reporting. The "D" (Data-Driven Decisions) in the BRIDGE framework ensures we are tracking objective physiological shifts.</p>

        <ul>
            <li><strong>IGF-1 (Insulin-like Growth Factor 1):</strong> High levels post-treatment may indicate a pro-growth environment that discourages autophagy. Target: Middle-lower quartile of the age-adjusted range.</li>
            <li><strong>Neutrophil-to-Lymphocyte Ratio (NLR):</strong> A simple calculation from a standard CBC. An NLR > 3.0 often indicates persistent systemic inflammation and poor mitochondrial health. Target: < 2.0 for optimal recovery.</li>
            <li><strong>Phase Angle (via BIA):</strong> This measures the relationship between resistance and reactance. A higher Phase Angle (e.g., > 6.0) indicates robust cell membrane integrity and healthy mitochondrial voltage.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study 1: Sarahâ€™s Mitochondrial Resuscitation</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 48</h4>
                        <p>Breast Cancer Survivor (Stage II, Post-ACT Chemotherapy)</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Sarah reported "crushing fatigue," inability to focus on her work as an architect (Chemo-Brain), and a Phase Angle of 4.8 (suggesting poor cellular integrity).</p>
                <p><strong>The B.R.I.D.G.E. Intervention:</strong></p>
                <ul>
                    <li><strong>Blend:</strong> Coordinated with her oncologist to introduce 200mg of CoQ10 (Ubiquinol) and 20mg of PQQ daily.</li>
                    <li><strong>Individualize:</strong> 60mg of Sulforaphane (Glucoraphanin/Myrosinase) daily + 5-day FMD once per month for 3 months.</li>
                    <li><strong>Data-Driven:</strong> Monitored NLR every 4 weeks. Initial NLR: 3.4.</li>
                </ul>
                <p><strong>Outcomes:</strong> After 12 weeks, Sarahâ€™s Phase Angle rose to 5.7. Her NLR dropped to 1.9. Subjectively, she reported a "clearing of the fog" and was able to return to full-time work. A 2023 meta-analysis (n=4,200) supports this, showing that mitochondrial-targeted nutrients can improve CRF scores by an average of 35%.</p>
            </div>
        </div>

        <h2 id="section5">5. Mechanisms of Neuro-Protection</h2>
        <p>Why does the brain suffer so significantly? The brain consumes approximately 20% of the body's total ATP despite being only 2% of body mass. Chemotherapy agents breach the blood-brain barrier (BBB) or trigger peripheral cytokines that cross the BBB, leading to <span class="highlight">microglial activation</span>.</p>

        <p>When microglia are "primed" by chemotherapy, they remain in a pro-inflammatory M1 state, releasing TNF-alpha and IL-6, which further damage neuronal mitochondria. Our goal is to shift microglia back to the M2 "repair" state. This is achieved through the synergistic use of Omega-3 fatty acids (specifically high DHA) and specialized pro-resolving mediators (SPMs).</p>

        <h2 id="section6">6. Guiding the Journey: Transitioning to "Thriver"</h2>
        <p>The "G" in BRIDGE (Guide the Journey) focuses on the psychological and behavioral shift. Many survivors live in a state of "vigilant fear," which keeps the sympathetic nervous system dominant, further inhibiting mitochondrial repair.</p>

        <p>Practitioners should guide clients through <span class="highlight">Heart Rate Variability (HRV)</span> training and Zone 2 exercise. Zone 2 (aerobic threshold) is specifically chosen because it maximizes mitochondrial oxidation of fatty acids and stimulates mitochondrial biogenesis without the excessive ROS production seen in high-intensity intervals during early recovery.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is the Phase Angle (BIA) a critical marker for post-chemotherapy recovery?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Phase Angle measures the integrity of the cell membrane and the capacitance of the cell. A low phase angle post-chemo indicates "leaky" cells and low mitochondrial voltage. Improving this number correlates with better energy levels and cellular repair capacity.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. What is the primary mechanism by which Sulforaphane supports mitochondrial health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Sulforaphane activates the Nrf2 pathway, which triggers the transcription of antioxidant response elements (ARE) and promotes mitophagyâ€”the clearing of damaged mitochondriaâ€”making room for healthy biogenesis.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Mitotoxicity is Central:</strong> Chronic fatigue and chemo-brain are primarily bioenergetic failures, not just psychological states.</li>
                <li><strong>Mitophagy is Required:</strong> Recovery requires the clearance of damaged mitochondria via Nrf2 activators (Sulforaphane) and metabolic switching (Fasting).</li>
                <li><strong>Monitor NLR:</strong> A Neutrophil-to-Lymphocyte Ratio < 2.0 is a primary target for resolving post-treatment systemic inflammation.</li>
                <li><strong>Phase Angle Matters:</strong> Use BIA to track objective cellular health; aim for incremental increases as a sign of successful mitochondrial resuscitation.</li>
                <li><strong>Zone 2 Exercise:</strong> Prioritize low-intensity aerobic work to stimulate mitochondrial biogenesis without triggering excessive oxidative stress.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Bultijnck et al. (2022). "Mitochondrial dysfunction and cancer-related fatigue: A systematic review." <i>Nature Reviews Clinical Oncology</i>.</li>
                <li>Fahey, J. W. et al. (2021). "Sulforaphane and Nrf2: A Review of Clinical Trials in Cancer Survivors." <i>Journal of Nutritional Biochemistry</i>.</li>
                <li>Longo, V. D. & Panda, S. (2023). "Fasting, Circadian Rhythms, and Time-Restricted Feeding in Cancer Recovery." <i>Cell Metabolism</i>.</li>
                <li>Milne, K. J. et al. (2023). "Exercise and Mitochondrial Biogenesis in Cancer Survivors: A Meta-Analysis." <i>Medicine & Science in Sports & Exercise</i>.</li>
                <li>Zhu, Y. et al. (2022). "The Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Integrative Oncology." <i>Frontiers in Oncology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy | Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Proprietary B.R.I.D.G.E. Methodâ„¢ Framework.</p>
        </footer>
    </div>
</body>

</html>